Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Covidien agrees new deal for medical isotope supply

Covidien agrees new deal for medical isotope supply

22nd February 2010

Covidien has signed an agreement with the Institute of Atomic Energy in Poland (IAE Polatom) over the provision of a new source of medical isotopes.

Under the terms of the agreement, IAE Polatom’s Maria Research Reactor is to become part of the medical device company’s global supply chain of Technetium 99m.

The isotope is regarded as a vital component in nuclear medicine diagnostic and functional studies and is used by radiologists, nephrologists and oncologists to study organs and anatomical systems.

Timothy Wright, president of pharmaceuticals at Covidien, described the deal as an “historic agreement”, as it is the first time in several decades that a new reactor has become part of the global medical isotope supply chain.

He added: “We are excited that we will now be working together to provide more than a million patients around the globe with access to a critical medical isotope during this serious shortage.”

Last month, the company published its financial breakdown for the first quarter of the fiscal year, during which its sales grew by seven per cent year-on-year.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.